Oncolytics Biotech Inc (ONCY) earnings
Quarterly results of Oncolytics Biotech Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 4 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Oncolytics Biotech Inc reported revenue of - and a net loss of $9.4M.
Diluted earnings per share were -$0.08.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$9.4M | -$0.08 |
| Q1 FY2026 | - | - | -$9.2M | -$0.08 |
| Q2 FY2025 | - | - | -$5.3M | -$0.06 |
| Q1 FY2025 | - | - | -$4.7M | -$0.06 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
Get an email when ONCY reports
Follow ONCY and we email you its next results the day they are filed, with the numbers explained.